Continuous Glucose Monitoring in Infants

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jul 2, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how continuous glucose monitoring can help track blood sugar levels in newborn infants, specifically those at risk for a condition called neonatal hypoglycemia, which means low blood sugar. The goal is to better understand how glucose levels change in these babies, which can help doctors provide better care.

To participate in this study, infants must be born at a healthy weight for their age or larger, and their mothers need to be at least 18 years old. However, infants born smaller than expected for their age or with certain health concerns cannot join. If eligible, participants will have a small device placed on their skin to continuously monitor their blood sugar levels, providing valuable information for their healthcare team. This trial is currently recruiting participants and aims to improve how we care for newborns with blood sugar issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Mother at least 18 years of age
• • Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)
• • Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers
• Exclusion Criteria:
• • Infants born small for gestational age (SGA)
• • Infant birth weight \<2.5 kg
• • Infant BMI \<10th percentile on Olsen chart
• • Infants born \<38 weeks gestation
• • Infants with concern for intrauterine growth restriction (IUGR) and short femur length based on ultrasound
• • Mother is non-English speaking